[1]Clark,JeremyL.;Hollecker,Laurent;Mason,J.Christian;Stuyver,LievenJ.;Tharnish,PhillipM.;Lostia,Stefania;McBrayer,TamaraR.;Schinazi,RaymondF.;Watanabe,KyoichiA.;Otto,MichaelJ.;Furman,PhillipA.;Stec,WojciechJ.;Patterson,StevenE.;Pankiewicz,KrzysztofW.[JournalofMedicinalChemistry,2005,vol.48,#17,p.5504-5508]
[2]CurrentPatentAssignee:JIANGSUCOLLEGEOFENGINEERINGANDTECHNOLOGY-CN111253454,2020,ALocationinpatent:Paragraph0052;0071-0072
[3]CurrentPatentAssignee:JIANGSUALPHARMPHARMACEUTICALGROUP-CN113354694,2021,ALocationinpatent:Paragraph0030-0035;0036-0039
[4]CurrentPatentAssignee:ZHEJIANGA&FUNIVERSITY-CN106905398,2017,ALocationinpatent:Paragraph0039;0047
[5]CurrentPatentAssignee:JIANGSUFURUIBIOPHARMACEUTICAL-CN106432388,2017,ALocationinpatent:Paragraph0048-0050
[6]Locationinpatent:experimentalpartSofia,MichaelJ.;Bao,Donghui;Chang,Wonsuk;Du,Jinfa;Nagarathnam,Dhanapalan;Rachakonda,Suguna;Reddy,P.Ganapati;Ross,BruceS.;Wang,Peiyuan;Zhang,Hai-Ren;Bansal,Shalini;Espiritu,Christine;Keilman,Meg;Lam,AngelaM.;Steuer,HollyM.Micolochick;Niu,Congrong;Otto,MichaelJ.;Furman,PhillipA.[JournalofMedicinalChemistry,2010,vol.53,#19,p.7202-7218]
[7]CurrentPatentAssignee:GILEADSCIENCESINC-WO2010/135569,2010,A1Locationinpatent:Page/Pagecolumn39-40
[8]CurrentPatentAssignee:GILEADSCIENCESINC-WO2013/40492,2013,A2Locationinpatent:Page/Pagecolumn101
[9]Maiti,Munmun;Maiti,Mohitosh;Rozenski,Jef;DeJonghe,Steven;Herdewijn,Piet[OrganicandBiomolecularChemistry,2015,vol.13,#18,p.5158-5174]
[10]CurrentPatentAssignee:OPTIMUSDRUGSP-WO2018/15821,2018,A1Locationinpatent:Page/Pagecolumn5;8
[11]CurrentPatentAssignee:GILEADSCIENCESINC-US2010/16251,2010,A1Locationinpatent:Page/Pagecolumn35
[12]CurrentPatentAssignee:NANJINGSANHOMEINVESTMENTGROUPCOLTD-CN108218937,2018,ALocationinpatent:Paragraph0089;0092-0093
[13]CurrentPatentAssignee:NANJINGSANHOMEINVESTMENTGROUPCOLTD-CN108201539,2018,ALocationinpatent:Paragraph0033;0036;0037
[14]CurrentPatentAssignee:NANTONGCHANGYOOPHARMATECH;NANTONGCHANGYOUPHARMACEUTICALTECHNOLOGY-CN104610404,2016,BLocationinpatent:Paragraph0047;0048;0063;0064
[15]CurrentPatentAssignee:ANHUIBIOCHEMUNITEDPHARMACEUTICALCO.,LTD.-CN103848876,2016,BLocationinpatent:Paragraph0109-0111
[16]CurrentPatentAssignee:CHENGDUPORTONPHARMACEUTICAL;PORTONFINECHEMICALSLIMITED-CN106366145,2017,ALocationinpatent:Paragraph0027
[17]CurrentPatentAssignee:SINOBIOPHARMACEUTICALLIMITED;SUZHOULANXITEBIOTECHNOLOGYCOLTD-CN104558079,2017,BLocationinpatent:Paragraph0041;0042
[18]CurrentPatentAssignee:FUZHOUXINGCHENPHARAMCEUTICAL-CN106810515,2017,ALocationinpatent:Paragraph0064;0066-0068
[19]Wang,Gang;Lim,SiewPheng;Chen,Yen-Liang;Hunziker,Jürg;Rao,Ranga;Gu,Feng;Seh,CheahChen;Ghafar,NahdiyahAbdul;Xu,Haoying;Chan,Katherine;Lin,Xiaodong;Saunders,OliverL.;Fenaux,Martijn;Zhong,Weidong;Shi,Pei-Yong;Yokokawa,Fumiaki[BioorganicandMedicinalChemistryLetters,2018,vol.28,#13,p.2324-2327]
[1]Clark,JeremyL.;Hollecker,Laurent;Mason,J.Christian;Stuyver,LievenJ.;Tharnish,PhillipM.;Lostia,Stefania;McBrayer,TamaraR.;Schinazi,RaymondF.;Watanabe,KyoichiA.;Otto,MichaelJ.;Furman,PhillipA.;Stec,WojciechJ.;Patterson,StevenE.;Pankiewicz,KrzysztofW.[JournalofMedicinalChemistry,2005,vol.48,#17,p.5504-5508]
[2]Maiti,Munmun;Maiti,Mohitosh;Rozenski,Jef;DeJonghe,Steven;Herdewijn,Piet[OrganicandBiomolecularChemistry,2015,vol.13,#18,p.5158-5174]
[3]CurrentPatentAssignee:NANTONGCHANGYOOPHARMATECH;NANTONGCHANGYOUPHARMACEUTICALTECHNOLOGY-CN104610404,2016,B
[4]CurrentPatentAssignee:ANHUIBIOCHEMUNITEDPHARMACEUTICALCO.,LTD.-CN103848876,2016,B
[5]CurrentPatentAssignee:ZHEJIANGA&FUNIVERSITY-CN106905398,2017,A
[6]CurrentPatentAssignee:OPTIMUSDRUGSP-WO2018/15821,2018,A1
[7]CurrentPatentAssignee:NANJINGSANHOMEINVESTMENTGROUPCOLTD-CN108218937,2018,A
[8]CurrentPatentAssignee:GILEADSCIENCESINC-US2010/16251,2010,A1
[1]Murakami,Eisuke;Niu,Congrong;Bao,Haiying;MicolochickSteuer,HollyM.;Whitaker,Tony;Nachman,Tammy;Sofia,MichaelA.;Wang,Peiyuan;Otto,MichaelJ.;Furman,PhillipA.[AntimicrobialAgentsandChemotherapy,2008,vol.52,#2,p.458-464]
[2]CurrentPatentAssignee:GILEADSCIENCESINC-WO2013/40492,2013,A2Locationinpatent:Page/Pagecolumn108
[3]CurrentPatentAssignee:GILEADSCIENCESINC-US2010/16251,2010,A1Locationinpatent:Page/Pagecolumn36
[1]CurrentPatentAssignee:GILEADSCIENCESINC-US2010/16251,2010,A1Locationinpatent:Page/Pagecolumn36
[1]CurrentPatentAssignee:GILEADSCIENCESINC-US2010/16251,2010,A1Locationinpatent:Page/Pagecolumn36-37
Title: Characterization of the metabolic activation of hepatitis C virus nucleoside inhibitor beta-D-2'-Deoxy-2'-fluoro-2'-C-methylcytidine (PSI-6130) and identification of a novel active 5'-triphosphate species.
Journal: The Journal of biological chemistry 20071012
Title: Design, synthesis, and antiviral activity of 2'-deoxy-2'-fluoro-2'-C-methylcytidine, a potent inhibitor of hepatitis C virus replication.
Journal: Journal of medicinal chemistry 20050825
Title: Clark JL, et al. Design, Synthesis, and Antiviral Activity of 2'-Deoxy-2'-fluoro-2'-C-methyl-cytidine, a Potent Inhibitor of Hepatitis C Virus Replication. J Med Chem. 2005 Aug 25;48(17):5504-8.
Title: Ma H, et al. Characterization of the metabolic activation of hepatitis C virus nucleoside inhibitor beta-D-2'-Deoxy-2'-fluoro-2'-C-methylcytidine (PSI-6130) and identification of a novel active 5'-triphosphate species. J Biol Chem. 2007 Oct 12;282(41):29
Title: Wang P, et al. An efficient and diastereoselective synthesis of PSI-6130: a clinically efficacious inhibitor of HCV NS5B polymerase. J Org Chem. 2009 Sep 4;74(17):6819-24.
